Ventricular Tachycardia

Clinical Trial Finder

Many patients with ventricular tachycardia are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias

Conditions:   Inherited Cardiac Arrythmias;   Long QT Syndrome (LQTS);   Brugada Syndrome (BrS);   Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT);   Early Repolarization Syndrome (ERS);   Arrhythmogenic Cardiomyopathy (AC, ARVD/C);   Hypertrophic Cardiomyopathy (HCM);   Dilated Cardiomyopathy (DCM);   Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy);   Normal Control Subjects
Sponsor:   Johns Hopkins University
Enrolling by invitation - verified April 2015

Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia

Condition:   Ventricular Tachycardia
Interventions:   Drug: Versed;   Drug: Fentanyl;   Drug: Propofol;   Drug: Sevoflurane
Sponsor:   Brigham and Women's Hospital
Recruiting - verified April 2015

Using Ripple Mapping to Guide Substrate Ablation of Scar Related Ventricular Tachycardia.

Conditions:   Monomorphic Ventricular Tachycardia;   Myocardial Infarction;   Dilated Cardiomyopathy
Interventions:   Device: Ripple Mapping guided VT ablation;   Device: Conventional VT ablation
Sponsor:   Imperial College London
Recruiting - verified July 2014

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator

Condition:   Ventricular Arrhythmia
Interventions:   Drug: GS-6615;   Drug: Placebo to match GS-6615
Sponsor:   Gilead Sciences
Recruiting - verified April 2015

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure

Condition:   Current or Recent History of Atrial Fibrillation
Interventions:   Drug: bucindolol hydrochloride;   Drug: metoprolol succinate
Sponsors:   ARCA Biopharma, Inc.;   Medtronic
Recruiting - verified April 2015

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

Condition:   Hypertrophic Cardiomyopathy
Intervention:   Other: None - this is an observational study
Sponsors:   University of Virginia;   National Heart, Lung, and Blood Institute (NHLBI);   Oxford University Hospitals NHS Trust
Recruiting - verified April 2015

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation FIBRILLATION

Conditions:   Ventricular Tachycardia;   Atrial Fibrillation
Interventions:   Drug: Ethanol;   Procedure: Ablation
Sponsors:   The Methodist Hospital System;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2015

Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

Conditions:   Atrial Fibrillation New Onset;   Hemorrhage;   Prolonged QTc Interval;   Ventricular Tachycardia;   Medical Care; Complications, Late Effect of Complications
Interventions:   Drug: Ranolazine;   Drug: Placebo
Sponsors:   North Shore Long Island Jewish Health System;   Gilead Sciences
Active, not recruiting - verified April 2015

Mechanical Alternans Study

Conditions:   Ischemic Cardiomyopathy;   Nonischemic Cardiomyopathy;   Heart Failure
Sponsor:   Johns Hopkins University
Completed - verified April 2015

Vest Prevention of Early Sudden Death Trial and VEST Registry

Conditions:   Myocardial Infarction;   Ventricular Dysfunction;   Sudden Death;   Ventricular Tachycardia;   Ventricular Fibrillation
Intervention:   Device: wearable defibrillator
Sponsors:   University of California, San Francisco;   Zoll Medical Corporation
Recruiting - verified April 2015

Left Ventricular Capture Management Study

Conditions:   Ventricular Fibrillation;   Ventricular Tachycardia;   Bradyarrhythmia
Sponsor:   Medtronic
Completed - verified April 2015

Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker

Conditions:   Ventricular Tachycardia;   Sudden Cardiac Death
Interventions:   Drug: Omegaven;   Drug: Isotonic saline
Sponsor:   Aalborg Universitetshospital  
Completed - verified April 2015

Registry of Unexplained Cardiac Arrest

Conditions:   Cardiac Arrest;   Long QT Syndrome;   Brugada Syndrome;   Catecholaminergi Polymorphic Ventricular Tachycardia;   Idiopathic VentricularFibrillation;   Early Repolarization Syndrome;   Arrhythmogenic Right Ventricular Cardiomyopathy
Sponsors:   University of British Columbia;   Heart and Stroke Foundation of Ontario;   Boston Scientific Corporation;   Medtronic
Recruiting - verified April 2015

Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)

Conditions:   Ischemic Cardiomyopathy;   LV Dysfunction
Intervention:   Device: T-Wave Alternans test
Sponsors:   St. Jude Medical;   Cambridge Heart Inc.;   MetroHealth Medical Center
Completed - verified April 2015

Get CardioSmart

You're Invited